当前位置：
X-MOL 学术
›
Mov. Disord.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Metabolic network abnormalities in drug-naïve Parkinson's Disease
Movement Disorders ( IF 7.4 ) Pub Date : 2019-12-24 , DOI: 10.1002/mds.27960 Katharina A Schindlbeck 1 , Olaia Lucas-Jiménez 2 , Chris C Tang 1 , Silvia Morbelli 3, 4 , Dario Arnaldi 3, 5 , Matteo Pardini 3, 5 , Marco Pagani 6, 7 , Naroa Ibarretxe-Bilbao 2 , Natalia Ojeda 2 , Flavio Nobili 3, 5 , David Eidelberg 1
Movement Disorders ( IF 7.4 ) Pub Date : 2019-12-24 , DOI: 10.1002/mds.27960 Katharina A Schindlbeck 1 , Olaia Lucas-Jiménez 2 , Chris C Tang 1 , Silvia Morbelli 3, 4 , Dario Arnaldi 3, 5 , Matteo Pardini 3, 5 , Marco Pagani 6, 7 , Naroa Ibarretxe-Bilbao 2 , Natalia Ojeda 2 , Flavio Nobili 3, 5 , David Eidelberg 1
Affiliation
An ideal imaging biomarker for a neurodegenerative disorder should be able to measure abnormalities in the earliest stages of the disease.
中文翻译：
未经药物治疗的帕金森氏病中的代谢网络异常
神经退行性疾病的理想成像生物标志物应该能够测量疾病早期阶段的异常情况。
更新日期：2019-12-24
中文翻译：
未经药物治疗的帕金森氏病中的代谢网络异常
神经退行性疾病的理想成像生物标志物应该能够测量疾病早期阶段的异常情况。
京公网安备 11010802027423号